Replication of Epstein-Barr virus in human epithelial cells infected in vitro - PubMed

• PMID: 6316160
• DOI: 10.1038/306480a0

Replication of Epstein-Barr virus in human epithelial cells infected in vitro

J W Sixbey et al. Nature. 1983 Dec.

Abstract

Epstein-Barr virus (EBV), a member of the herpes group of viruses and the aetiological agent of infectious mononucleosis, is usually thought of as a lymphotrophic virus with the ability to transform B lymphocytes. So the association of EBV with nasopharyngeal carcinoma is puzzling, especially given the lack of success of attempts to infect epithelial cells with EBV in culture and the apparent lack of EBV receptors on epithelial cells. Circumvention of the apparent requirement for membrane receptors by techniques of transfection, microinjection and receptor transplantation has clearly demonstrated that there is no inherent barrier to EBV replication in nonlymphoid cells, including epithelial cell types. Our ability routinely to detect EBV DNA by in situ hybridization in epithelial cells of the oropharynx from persons with acute infectious mononucleosis suggests that, in vivo, EBV regularly gains access to and replicates lytically in epithelial cells. We report here in vitro evidence for direct infection by EBV and replication of the virus in cultured normal human epithelial cells.

Similar articles

• Infection of normal human thymic epithelial cells by Epstein-Barr virus (EBV) following implantation of EBV receptors.

  Seshi B, Volsky B, Anderson RW, Purtilo DT, Volsky DJ. Seshi B, et al. Thymus. 1984;6(1-2):5-13. Thymus. 1984. PMID: 6087504

• Epstein-Barr virus replication in oropharyngeal epithelial cells.

  Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Sixbey JW, et al. N Engl J Med. 1984 May 10;310(19):1225-30. doi: 10.1056/NEJM198405103101905. N Engl J Med. 1984. PMID: 6323983

• Replication of Epstein-Barr virus DNA in epithelial cells in vivo.

  Lemon SM, Hutt LM, Shaw JE, Li JL, Pagano JS. Lemon SM, et al. IARC Sci Publ (1971). 1978;(24 Pt 2):739-44. IARC Sci Publ (1971). 1978. PMID: 221397

• Physicochemical-viral synergism during Epstein-Barr virus infection: a review.

  Henderson EE. Henderson EE. J Natl Cancer Inst. 1988 Jun 1;80(7):476-83. doi: 10.1093/jnci/80.7.476. J Natl Cancer Inst. 1988. PMID: 2835490 Review.

Cited by

• Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential.

  Sixbey JW, Shirley P. Sixbey JW, et al. Springer Semin Immunopathol. 1991;13(2):167-79. doi: 10.1007/BF00201467. Springer Semin Immunopathol. 1991. PMID: 1664984 Review. No abstract available.

• Does neoplasia in-situ develop due to the interaction of Epstein-Barr virus or herpes simplex virus-2 with Langerhans cells in the epithelium?

  Becker Y. Becker Y. Virus Genes. 1988 Jul;1(4):385-97. doi: 10.1007/BF00257101. Virus Genes. 1988. PMID: 2852413 Review. No abstract available.

• Epithelial cell infection by Epstein-Barr virus.

  Chen J, Longnecker R. Chen J, et al. FEMS Microbiol Rev. 2019 Nov 1;43(6):674-683. doi: 10.1093/femsre/fuz023. FEMS Microbiol Rev. 2019. PMID: 31584659 Free PMC article.

• ERK2 phosphorylation of EBNA1 serine 383 residue is important for EBNA1-dependent transactivation.

  Noh KW, Park J, Joo EH, Lee EK, Choi EY, Kang MS. Noh KW, et al. Oncotarget. 2016 May 3;7(18):25507-15. doi: 10.18632/oncotarget.8177. Oncotarget. 2016. PMID: 27009860 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group